The upgrade from Morgan Stanley is a positive signal for Pharvaris, indicating increased confidence in the company's prospects. This has led to a rise in the stock's price. The raised price target also suggests that Morgan Stanley believes the stock has significant upside potential, which could attract more investors and further drive up the stock price.